Comparative Treatment Planning on Localized Prostate Carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-07

AUTHORS

Ulrike Mock, Joachim Bogner, Dietmar Georg, Thomas Auberger, Richard Pötter

ABSTRACT

Purpose:To assess the potential benefit of proton–beam therapy in comparison to 3–D conformal photon therapy and photon– based intensity–modulated radiotherapy (IMRT) in prostate carcinoma for various stages of disease.Material and Methods:In five patients a 3–D conformal proton–based (two lateral beams) irradiation technique was compared with 3–D conformal photon–beam radiotherapy (four–field box) and IMRT (seven beams). For each patient different target volumes (CTVs) were defined according to early, intermediate and advanced stages of disease: CTV I consisted of the prostate gland, CTV II encompassed prostate and basis of seminal vesicles, and CTV III the prostate and seminal vesicles. Corresponding planning target volumes PTV I–III were defined by uniformly adding a margin of 5 mm to CTV I–III. Dose–volume histograms (DVHs) were analyzed for the different PTVs and various organs at risk (OARs), i.e., rectal wall, bladder, both femoral heads. In addition, maximum and mean doses were derived for the various structures and irradiated non–target tissue volumes were compared for PTV I–III and the different irradiation techniques. Finally, dose conformity and target dose homogeneity were assessed.Results:With photon– and proton–based radiotherapy techniques similar dose distributions were determined for PTV I–III: mean and maximum PTV dose values were between 99–104% and 102–107% of the normalized total doses (70 Gy), respectively. Conformity indices varied from 1.4 to 1.5 for the photon techniques, whereas for proton–beam radiotherapy values ranged from 1.1 to 1.4. Both the 3–D conformal and the IMRT photon treatment technique resulted in increased mean doses (~ 40–80%) for OARs when compared to protons. With both photon techniques non–target tissue volumes were irradiated to higher doses (mean dose difference ≥ 70%) compared to proton–beam radiotherapy. Differences occurred mainly at the low and medium dose levels, whereas in high dose levels similar values were obtained. In comparison to conformal 3–D treatments IMRT reduced doses to OARs in the medium dose range, especially for the rectal wall.Conclusion:IMRT enabled dose reductions to OARs in the medium dose range compared to 3–D conformal radiotherapy. A rather simple two–field proton–based treatment technique further reduced doses to OARs compared to photon–beam radiotherapy. The advantageous dose distribution of proton–beam therapy for prostate cancer may result in reduced side effects, which needs to be confirmed in clinical studies. More... »

PAGES

448-455

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00066-005-1317-7

DOI

http://dx.doi.org/10.1007/s00066-005-1317-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016962412

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15995838


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femur", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Photons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Conformal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rectum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urinary Bladder", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Abteilung f\u00fcr Radiotherapie und Radiobiologie, Allgemeines Krankenhaus der Stadt Wien, W\u00e4hringer G\u00fcrtel 18\u201320, 1090, Wien, Austria", 
          "id": "http://www.grid.ac/institutes/grid.411904.9", 
          "name": [
            "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria", 
            "Abteilung f\u00fcr Radiotherapie und Radiobiologie, Allgemeines Krankenhaus der Stadt Wien, W\u00e4hringer G\u00fcrtel 18\u201320, 1090, Wien, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mock", 
        "givenName": "Ulrike", 
        "id": "sg:person.01265025607.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265025607.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bogner", 
        "givenName": "Joachim", 
        "id": "sg:person.0730417316.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730417316.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Georg", 
        "givenName": "Dietmar", 
        "id": "sg:person.01100042703.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100042703.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiotherapy, Medical University of Innsbruck, Innsbruck, Austria", 
          "id": "http://www.grid.ac/institutes/grid.5361.1", 
          "name": [
            "Department of Radiotherapy, Medical University of Innsbruck, Innsbruck, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Auberger", 
        "givenName": "Thomas", 
        "id": "sg:person.0656646537.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656646537.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "P\u00f6tter", 
        "givenName": "Richard", 
        "id": "sg:person.01320547655.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320547655.05"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00066-003-1058-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033111509", 
          "https://doi.org/10.1007/s00066-003-1058-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00066-004-1337-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008939107", 
          "https://doi.org/10.1007/s00066-004-1337-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00002302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033245623", 
          "https://doi.org/10.1007/pl00002302"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-07", 
    "datePublishedReg": "2005-07-01", 
    "description": "Purpose:To assess the potential benefit of proton\u2013beam therapy in comparison to 3\u2013D conformal photon therapy and photon\u2013\nbased intensity\u2013modulated radiotherapy (IMRT) in prostate carcinoma for various stages of disease.Material and Methods:In five patients a 3\u2013D conformal proton\u2013based (two lateral beams) irradiation technique was compared\nwith 3\u2013D conformal photon\u2013beam radiotherapy (four\u2013field box) and IMRT (seven beams). For each patient different target volumes\n(CTVs) were defined according to early, intermediate and advanced stages of disease: CTV I consisted of the prostate gland, CTV\nII encompassed prostate and basis of seminal vesicles, and CTV III the prostate and seminal vesicles. Corresponding planning\ntarget volumes PTV I\u2013III were defined by uniformly adding a margin of 5 mm to CTV I\u2013III. Dose\u2013volume histograms (DVHs) were\nanalyzed for the different PTVs and various organs at risk (OARs), i.e., rectal wall, bladder, both femoral heads. In addition,\nmaximum and mean doses were derived for the various structures and irradiated non\u2013target tissue volumes were compared for PTV\nI\u2013III and the different irradiation techniques. Finally, dose conformity and target dose homogeneity were assessed.Results:With photon\u2013 and proton\u2013based radiotherapy techniques similar dose distributions were determined for PTV I\u2013III: mean\nand maximum PTV dose values were between 99\u2013104% and 102\u2013107% of the normalized total doses (70 Gy), respectively. Conformity\nindices varied from 1.4 to 1.5 for the photon techniques, whereas for proton\u2013beam radiotherapy values ranged from 1.1\nto 1.4. Both the 3\u2013D conformal and the IMRT photon treatment technique resulted in increased mean doses (~ 40\u201380%) for OARs\nwhen compared to protons. With both photon techniques non\u2013target tissue volumes were irradiated to higher doses (mean dose\ndifference \u2265 70%) compared to proton\u2013beam radiotherapy. Differences occurred mainly at the low and medium dose levels,\nwhereas in high dose levels similar values were obtained. In comparison to conformal 3\u2013D treatments IMRT reduced doses to OARs\nin the medium dose range, especially for the rectal wall.Conclusion:IMRT enabled dose reductions to OARs in the medium dose range compared to 3\u2013D conformal radiotherapy. A rather\nsimple two\u2013field proton\u2013based treatment technique further reduced doses to OARs compared to photon\u2013beam radiotherapy. The\nadvantageous dose distribution of proton\u2013beam therapy for prostate cancer may result in reduced side effects, which needs to be\nconfirmed in clinical studies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00066-005-1317-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054450", 
        "issn": [
          "0179-7158", 
          "1439-099X"
        ], 
        "name": "Strahlentherapie und Onkologie", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "181"
      }
    ], 
    "keywords": [
      "intensity-modulated radiotherapy", 
      "proton beam therapy", 
      "dose-volume histograms", 
      "medium dose range", 
      "mean doses", 
      "prostate carcinoma", 
      "rectal wall", 
      "dose range", 
      "conformal photon therapy", 
      "comparative treatment planning", 
      "stage of disease", 
      "seminal vesicles", 
      "tissue volume", 
      "localized prostate carcinoma", 
      "proton beam radiotherapy", 
      "target dose homogeneity", 
      "medium dose levels", 
      "different target volumes", 
      "photon beam radiotherapy", 
      "prostate cancer", 
      "clinical studies", 
      "dose reduction", 
      "conformal radiotherapy", 
      "similar dose distributions", 
      "side effects", 
      "dose levels", 
      "prostate gland", 
      "high doses", 
      "advanced stage", 
      "radiotherapy", 
      "femoral head", 
      "total doses", 
      "target volume", 
      "different irradiation techniques", 
      "dose homogeneity", 
      "treatment techniques", 
      "advantageous dose distributions", 
      "dose distribution", 
      "photon therapy", 
      "doses", 
      "therapy", 
      "photon techniques", 
      "treatment planning", 
      "OARs", 
      "carcinoma", 
      "prostate", 
      "disease", 
      "PTV", 
      "irradiation technique", 
      "potential benefits", 
      "different PTVs", 
      "dose values", 
      "patients", 
      "bladder", 
      "cancer", 
      "CTV", 
      "gland", 
      "treatment", 
      "risk", 
      "organs", 
      "volume", 
      "vesicles", 
      "head", 
      "stage", 
      "index", 
      "levels", 
      "wall", 
      "differences", 
      "study", 
      "similar values", 
      "benefits", 
      "reduction", 
      "comparison", 
      "effect", 
      "values", 
      "technique", 
      "addition", 
      "margin", 
      "photons", 
      "protons", 
      "planning", 
      "basis", 
      "range", 
      "distribution", 
      "conformal", 
      "method", 
      "conformity", 
      "materials", 
      "histogram", 
      "maximum", 
      "homogeneity", 
      "structure"
    ], 
    "name": "Comparative Treatment Planning on Localized Prostate Carcinoma", 
    "pagination": "448-455", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016962412"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00066-005-1317-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15995838"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00066-005-1317-7", 
      "https://app.dimensions.ai/details/publication/pub.1016962412"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_411.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00066-005-1317-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00066-005-1317-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00066-005-1317-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00066-005-1317-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00066-005-1317-7'


 

This table displays all metadata directly associated to this object as RDF triples.

249 TRIPLES      22 PREDICATES      134 URIs      123 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00066-005-1317-7 schema:about N04baf1cfb95246c6a3be02a5e06f3731
2 N1bc6e8ab4f97412a8d9e249a2e8c4113
3 N58cc4bc328014d5b93df1ece8af8e49a
4 N5beae080e399478a906c561373725392
5 Nb33836d3fc454122a4dcf61b269d0baa
6 Nc1f9b1e0c5204e758f4bceeefc46ff59
7 Nccfc67d97db34c05868dcfccaff578a7
8 Nce8b29ba75b34eac8716b25d70a6a581
9 Ndfdcfb0d5b374ef69ec28d76c426159c
10 Ne9aee4e935824fe4888f375987134794
11 Nea2d953cd1794cbfa25340733090e4a7
12 Nf7682165526346f388f73a2900d9cb32
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nb58c954f93ab4c958ab527ab02244f54
16 schema:citation sg:pub.10.1007/pl00002302
17 sg:pub.10.1007/s00066-003-1058-4
18 sg:pub.10.1007/s00066-004-1337-8
19 schema:datePublished 2005-07
20 schema:datePublishedReg 2005-07-01
21 schema:description Purpose:To assess the potential benefit of proton–beam therapy in comparison to 3–D conformal photon therapy and photon– based intensity–modulated radiotherapy (IMRT) in prostate carcinoma for various stages of disease.Material and Methods:In five patients a 3–D conformal proton–based (two lateral beams) irradiation technique was compared with 3–D conformal photon–beam radiotherapy (four–field box) and IMRT (seven beams). For each patient different target volumes (CTVs) were defined according to early, intermediate and advanced stages of disease: CTV I consisted of the prostate gland, CTV II encompassed prostate and basis of seminal vesicles, and CTV III the prostate and seminal vesicles. Corresponding planning target volumes PTV I–III were defined by uniformly adding a margin of 5 mm to CTV I–III. Dose–volume histograms (DVHs) were analyzed for the different PTVs and various organs at risk (OARs), i.e., rectal wall, bladder, both femoral heads. In addition, maximum and mean doses were derived for the various structures and irradiated non–target tissue volumes were compared for PTV I–III and the different irradiation techniques. Finally, dose conformity and target dose homogeneity were assessed.Results:With photon– and proton–based radiotherapy techniques similar dose distributions were determined for PTV I–III: mean and maximum PTV dose values were between 99–104% and 102–107% of the normalized total doses (70 Gy), respectively. Conformity indices varied from 1.4 to 1.5 for the photon techniques, whereas for proton–beam radiotherapy values ranged from 1.1 to 1.4. Both the 3–D conformal and the IMRT photon treatment technique resulted in increased mean doses (~ 40–80%) for OARs when compared to protons. With both photon techniques non–target tissue volumes were irradiated to higher doses (mean dose difference ≥ 70%) compared to proton–beam radiotherapy. Differences occurred mainly at the low and medium dose levels, whereas in high dose levels similar values were obtained. In comparison to conformal 3–D treatments IMRT reduced doses to OARs in the medium dose range, especially for the rectal wall.Conclusion:IMRT enabled dose reductions to OARs in the medium dose range compared to 3–D conformal radiotherapy. A rather simple two–field proton–based treatment technique further reduced doses to OARs compared to photon–beam radiotherapy. The advantageous dose distribution of proton–beam therapy for prostate cancer may result in reduced side effects, which needs to be confirmed in clinical studies.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N958369db4b59407a9b23d12062e44979
26 Nd962887662e7493883a9a63b01ea8ee9
27 sg:journal.1054450
28 schema:keywords CTV
29 OARs
30 PTV
31 addition
32 advanced stage
33 advantageous dose distributions
34 basis
35 benefits
36 bladder
37 cancer
38 carcinoma
39 clinical studies
40 comparative treatment planning
41 comparison
42 conformal
43 conformal photon therapy
44 conformal radiotherapy
45 conformity
46 differences
47 different PTVs
48 different irradiation techniques
49 different target volumes
50 disease
51 distribution
52 dose distribution
53 dose homogeneity
54 dose levels
55 dose range
56 dose reduction
57 dose values
58 dose-volume histograms
59 doses
60 effect
61 femoral head
62 gland
63 head
64 high doses
65 histogram
66 homogeneity
67 index
68 intensity-modulated radiotherapy
69 irradiation technique
70 levels
71 localized prostate carcinoma
72 margin
73 materials
74 maximum
75 mean doses
76 medium dose levels
77 medium dose range
78 method
79 organs
80 patients
81 photon beam radiotherapy
82 photon techniques
83 photon therapy
84 photons
85 planning
86 potential benefits
87 prostate
88 prostate cancer
89 prostate carcinoma
90 prostate gland
91 proton beam radiotherapy
92 proton beam therapy
93 protons
94 radiotherapy
95 range
96 rectal wall
97 reduction
98 risk
99 seminal vesicles
100 side effects
101 similar dose distributions
102 similar values
103 stage
104 stage of disease
105 structure
106 study
107 target dose homogeneity
108 target volume
109 technique
110 therapy
111 tissue volume
112 total doses
113 treatment
114 treatment planning
115 treatment techniques
116 values
117 vesicles
118 volume
119 wall
120 schema:name Comparative Treatment Planning on Localized Prostate Carcinoma
121 schema:pagination 448-455
122 schema:productId Nc303175734d74876a8883b43e8aad0eb
123 Nd2815b5b5f7a41d99d8964d4250f1660
124 Nde812dffb79b4d00aa8d557480529584
125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016962412
126 https://doi.org/10.1007/s00066-005-1317-7
127 schema:sdDatePublished 2022-06-01T22:06
128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
129 schema:sdPublisher N484ace4343b34acab9e802433670e57a
130 schema:url https://doi.org/10.1007/s00066-005-1317-7
131 sgo:license sg:explorer/license/
132 sgo:sdDataset articles
133 rdf:type schema:ScholarlyArticle
134 N04baf1cfb95246c6a3be02a5e06f3731 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N1bc6e8ab4f97412a8d9e249a2e8c4113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Neoplasm Staging
139 rdf:type schema:DefinedTerm
140 N484ace4343b34acab9e802433670e57a schema:name Springer Nature - SN SciGraph project
141 rdf:type schema:Organization
142 N58cc4bc328014d5b93df1ece8af8e49a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Radiotherapy, Conformal
144 rdf:type schema:DefinedTerm
145 N5a431de352ce4a5d8340e8e8c3099bbd rdf:first sg:person.01320547655.05
146 rdf:rest rdf:nil
147 N5beae080e399478a906c561373725392 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Femur
149 rdf:type schema:DefinedTerm
150 N8a787755e100483d9c11159aae0d3f45 rdf:first sg:person.01100042703.07
151 rdf:rest Ncab5339e2ddc475d81fa3d7711e6828a
152 N958369db4b59407a9b23d12062e44979 schema:issueNumber 7
153 rdf:type schema:PublicationIssue
154 N9c0d4cf2c27d45aa8452df2ae396f4fa rdf:first sg:person.0730417316.21
155 rdf:rest N8a787755e100483d9c11159aae0d3f45
156 Nb33836d3fc454122a4dcf61b269d0baa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Radiotherapy, Computer-Assisted
158 rdf:type schema:DefinedTerm
159 Nb58c954f93ab4c958ab527ab02244f54 rdf:first sg:person.01265025607.39
160 rdf:rest N9c0d4cf2c27d45aa8452df2ae396f4fa
161 Nc1f9b1e0c5204e758f4bceeefc46ff59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Urinary Bladder
163 rdf:type schema:DefinedTerm
164 Nc303175734d74876a8883b43e8aad0eb schema:name dimensions_id
165 schema:value pub.1016962412
166 rdf:type schema:PropertyValue
167 Ncab5339e2ddc475d81fa3d7711e6828a rdf:first sg:person.0656646537.34
168 rdf:rest N5a431de352ce4a5d8340e8e8c3099bbd
169 Nccfc67d97db34c05868dcfccaff578a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Prostatic Neoplasms
171 rdf:type schema:DefinedTerm
172 Nce8b29ba75b34eac8716b25d70a6a581 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Radiotherapy Dosage
174 rdf:type schema:DefinedTerm
175 Nd2815b5b5f7a41d99d8964d4250f1660 schema:name doi
176 schema:value 10.1007/s00066-005-1317-7
177 rdf:type schema:PropertyValue
178 Nd962887662e7493883a9a63b01ea8ee9 schema:volumeNumber 181
179 rdf:type schema:PublicationVolume
180 Nde812dffb79b4d00aa8d557480529584 schema:name pubmed_id
181 schema:value 15995838
182 rdf:type schema:PropertyValue
183 Ndfdcfb0d5b374ef69ec28d76c426159c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Protons
185 rdf:type schema:DefinedTerm
186 Ne9aee4e935824fe4888f375987134794 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Photons
188 rdf:type schema:DefinedTerm
189 Nea2d953cd1794cbfa25340733090e4a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Rectum
191 rdf:type schema:DefinedTerm
192 Nf7682165526346f388f73a2900d9cb32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Male
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
199 schema:name Oncology and Carcinogenesis
200 rdf:type schema:DefinedTerm
201 sg:journal.1054450 schema:issn 0179-7158
202 1439-099X
203 schema:name Strahlentherapie und Onkologie
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.01100042703.07 schema:affiliation grid-institutes:grid.22937.3d
207 schema:familyName Georg
208 schema:givenName Dietmar
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100042703.07
210 rdf:type schema:Person
211 sg:person.01265025607.39 schema:affiliation grid-institutes:grid.411904.9
212 schema:familyName Mock
213 schema:givenName Ulrike
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265025607.39
215 rdf:type schema:Person
216 sg:person.01320547655.05 schema:affiliation grid-institutes:grid.22937.3d
217 schema:familyName Pötter
218 schema:givenName Richard
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320547655.05
220 rdf:type schema:Person
221 sg:person.0656646537.34 schema:affiliation grid-institutes:grid.5361.1
222 schema:familyName Auberger
223 schema:givenName Thomas
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656646537.34
225 rdf:type schema:Person
226 sg:person.0730417316.21 schema:affiliation grid-institutes:grid.22937.3d
227 schema:familyName Bogner
228 schema:givenName Joachim
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730417316.21
230 rdf:type schema:Person
231 sg:pub.10.1007/pl00002302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033245623
232 https://doi.org/10.1007/pl00002302
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/s00066-003-1058-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033111509
235 https://doi.org/10.1007/s00066-003-1058-4
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s00066-004-1337-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008939107
238 https://doi.org/10.1007/s00066-004-1337-8
239 rdf:type schema:CreativeWork
240 grid-institutes:grid.22937.3d schema:alternateName Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria
241 schema:name Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria
242 rdf:type schema:Organization
243 grid-institutes:grid.411904.9 schema:alternateName Abteilung für Radiotherapie und Radiobiologie, Allgemeines Krankenhaus der Stadt Wien, Währinger Gürtel 18–20, 1090, Wien, Austria
244 schema:name Abteilung für Radiotherapie und Radiobiologie, Allgemeines Krankenhaus der Stadt Wien, Währinger Gürtel 18–20, 1090, Wien, Austria
245 Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria
246 rdf:type schema:Organization
247 grid-institutes:grid.5361.1 schema:alternateName Department of Radiotherapy, Medical University of Innsbruck, Innsbruck, Austria
248 schema:name Department of Radiotherapy, Medical University of Innsbruck, Innsbruck, Austria
249 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...